Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Fondaparinux MeSH Descriptor Data 2026


MeSH Heading
Fondaparinux
Tree Number(s)
D09.698.629.429
Unique ID
D000077425
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077425
Scope Note
Synthetic pentasaccharide that mediates the interaction of HEPARIN with ANTITHROMBINS and inhibits FACTOR Xa; it is used for prevention of VENOUS THROMBOEMBOLISM after surgery.
Entry Term(s)
Arixtra
Fondaparinux Sodium
Quixidar
Pharm Action
Factor Xa Inhibitors
Registry Numbers
J177FOW5JL
X0Q6N9USOZ
0
Related Numbers
X0Q6N9USOZ
CAS Type 1 Name
(2S,3S,4R,5R,6R)-6-((2R,3R,4R,5R,6R)-6-((2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl)oxy-5-sulfooxyoxan-3-yl)oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl)oxy-3-((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl)oxy-4,5-dihydroxyoxane-2-carboxylic acid
Public MeSH Note
2019; FONDAPARINUX was indexed under POLYSACCHARIDES 2001-2018
History Note
2019 (2001)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Fondaparinux Preferred
Fondaparinux Sodium Narrower
Arixtra Narrower
Quixidar Narrower
page delivered in 0.137s